GovChime
Notice ID: 6c258f5d723e4af5851594cd11c76d55Award NoticeAwarded

Ibandronate Sodium Tablets

Awarded on May 7, 2026. Full description on SAM.gov.

Awarded tounder SPE2D2-26-D-0015 (source: SAM.gov award notice)• $2.4M

Overview

Posted
May 7, 2026
Notice type
Award Notice
NAICS
325412: Pharmaceutical Preparation Manufacturing
Agency
Department of WarDEFENSE LOGISTICS AGENCY

Notice details

Office
TROOP SUPPORT MEDICAL.DLA TROOP SUPPORT
Place of performance
Etobicoke, Ontario
PSC
6505: DRUGS AND BIOLOGICALS
Last updated
Oct 28, 2026
First published
Last updated on SAM.gov
Award date
May 7, 2026
Award amount (SAM.gov award notice)
$2.4M

Identifiers

Solicitation number
SPE2D2-26-D-0015
Notice ID
6c258f5d723e4af5851594cd11c76d55
Award number (PIID)
SPE2D2-26-D-0015

Description

SPE2D2-26-D-0015 Ibandronate Sodium Award

Full description on SAM.gov

Award Overview

Award Number

SPE2D2-26-D-0015

Award Amount (SAM.gov award notice)

$2.4M

Award Date

May 7, 2026

Awardee

Awardee UEI

GQLDJJ8AQNN5

Awardee CAGE Code

1HT23

Awardee Address

Camarillo, CA 93012, UNITED STATES

Line Item Number

SPE2D2-26-D-0015

Original Solicitation

Notice ID: 6c258f5d723e4af5851594cd11c76d55

Posted Date: May 7, 2026

Original Response Deadline: Not specified

Contacts

Contracting Officer

Primary Contact

Secondary Contact

Documents

Files (1)

  • Ibandronate Sodium - SPE2D2-26-D-0015 signed award.pdf

    967 KBAdded in Award Notice version 3Posted
    Download

Lifecycle

  1. 2
    Version 2Combined Synopsis/SolicitationArchived

    Ibandronate Sodium Tablets

    Notice b4edba82212d4da6a258c458be450126 on SAM.gov

  2. 3
    Version 3Award NoticeCurrent

    Type changed from Combined Synopsis/Solicitation to Award Notice

    Ibandronate Sodium Tablets

    Notice 6c258f5d723e4af5851594cd11c76d55 on SAM.gov

Similar Opportunities

Additional Details

Solicitation Number

SPE2D2-26-D-0015

Archive Date

May 7, 2031

Place of Performance Country

CANADA

Office Address

PHILADELPHIA, PA, 19111